Table 4

Main characteristics of patients with rheumatoid arthritis included in this study according to the presence or absence of metabolic syndrome
Characteristics Total (n=120) Mets absent (n=83) Mets present (n=37) P value
Mean Age (years)1 49± 12 47±12 52±10 0.03
Female Sex n (%)2 110 (91.7 ) 74(89.2) 36(97.3) 0.13
Menopause n(%)2 63(51.1) 38(45.8) 25(67.6) 0.02
RF positive n (%)2 93(76) 65(78.3) 28(75.7) 0.74
ACPA positive n (%)2 104(85) 73(88) 31(83) 0.53
Disease duration (yrs)1 7.8 ± 5.3 7.5±5.4 8.5± 4.9 0.31
CRP (mg/L)1 17(1à 112) 17±21 19±19 0.59
ESR (mm 1erhour)1 33± 23 24± 23 37± 24 0.04
DAS281 5 ± 1.4 4.9±1.3 5.2± 1.5 0.32
Global pain (VAS : 0-100 mm)1 54 ± 21 57±17 53±20 0.36
HAQ1 1.4± 0.7 1.1±0.7 1.5±0.7 0.04
Methotrexate n (%)2 117(96) 80(96) 37(100) 0.24
glucocorticoids mean daily dose (mg/j)1 7.3±3.05 7.5±2.3 8±2.4 0.44

1: Mean ± standard deviation, 2: number (percentage). ACPA = anti-cyclic citrullinated peptide; BP = blood pressure; CRP = C-reactive protein; DAS =Disease Activity Score; ESR = erythrocyte sedimentation rate; HAQ = Health Assessment Questionnaire; HDL =high-density lipoprotein; MetS = metabolic syndrome; RA = rheumatoid arthritis; RF = rheumatoid facto; BMI= Body mass index; VAS= visual analogic scale.

Rostom et al.

Rostom et al. BMC Musculoskeletal Disorders 2013 14:147   doi:10.1186/1471-2474-14-147

Open Data